Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.39 |
| ▸ | CA1 | P00915 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | CA9 | Q16790 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TYMP | P19971 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.32 |
| ▸ | APLNR | P35414 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15899140 | 0.92 | CA12 (0.41) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18589129 | 0.90 | CA12 (0.38) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18633388 | 0.88 | CA12 (0.39) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL29705195 | 0.83 | CA12 (0.37) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18577905 | 0.82 | CYP3A4 (0.34) | CA12CA1CA2CA9CYP3A4 | |
| SCHEMBL18577912 | 0.81 | CA12 (0.39) | CA12CA1CA2CA9KMT2A | |
| SCHEMBL18577891 | 0.81 | CYP1A2 (0.33) | CA12CA1CA2CA9CYP3A4 | |
| SCHEMBL18577886 | 0.81 | CYP1A2 (0.33) | CA12CA1CA2CA9CYP3A4 | |
| SCHEMBL18577916 | 0.81 | CYP1A2 (0.33) | CA12CA1CA2CA9CYP3A4 | |
| SCHEMBL15899135 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282857-B1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | INST OF SCIENCE TOKYO (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2024-02-01 | — | — | US | disclosed |
| EP-4282857-A1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | Tokyo Institute of Technology (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-11318216-B2 | Method for producing radiohalogen-labeled compound and method for producing radiopharmaceutical | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2022-05-03 | — | — | US | disclosed |
| EP-3536686-B1 | METHOD FOR PRODUCING A RADIOPHARMACEUTICAL COMPOSITION | NIHON MEDIPHYSICS CO LTD (JP) | 2021-11-24 | — | — | EP | disclosed |
| US-10703726-B2 | Method for producing radiopharmaceutical composition | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
| EP-3643710-A1 | PRODUCTION METHOD FOR RADIOHALOGEN-LABELED COMPOUND AND PRODUCTION METHOD FOR RAIDOPHARMACEUTICAL | Nihon Medi-Physics Co., Ltd. (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-20200121811-A1 | METHOD FOR PRODUCING RADIOHALOGEN-LABELED COMPOUND AND METHOD FOR PRODUCING RADIOPHARMACEUTICAL | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2020-04-23 | — | — | US | disclosed |
| CN-110809575-A | Method for producing radioactive halogen-labeled compound and method for producing radiopharmaceutical | 日本医事物理股份有限公司 | 2020-02-18 | — | — | CN | disclosed |
| US-20190276411-A1 | Method for Producing Radiopharmaceutical Composition | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2019-09-12 | — | — | US | disclosed |
| US-20170066748-A1 | RADIOACTIVE FLUORINE LABELING PRECURSOR COMPOUND AND METHOD FOR MANUFACTURING RADIOACTIVE FLUORINE LABELED COMPOUND USING THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| EP-2759538-B1 | RADIOACTIVE FLUORINE LABELED COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-2759538-B1 | RADIOACTIVE FLUORINE LABELED COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-9107964-B2 | Radioactive fluorine-labeled compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9107964-B2 | Radioactive fluorine-labeled compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20140364620-A1 | RADIOACTIVE FLUORINE-LABELED COMPOUND | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2014-12-11 | — | — | US | disclosed |
| US-20140364620-A1 | RADIOACTIVE FLUORINE-LABELED COMPOUND | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2014-12-11 | — | — | US | disclosed |
| EP-2759538-A1 | RADIOACTIVE FLUORINE LABELED COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2014-07-30 | — | — | EP | disclosed |
| EP-2759538-A1 | RADIOACTIVE FLUORINE LABELED COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013042668-A1 | RADIOACTIVE FLUORINE LABELED COMPOUND | 日本メジフィジックス株式会社 (JP) | 2013-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364620-A1 | RADIOACTIVE FLUORINE-LABELED COMPOUND | AFF1, PRMT1, DOT1L | CA12 1215/4885CA1 667/4885CA2 2376/4885 |
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | GPR119, SLC5A2, GCKR | CA12 616/4885CA1 1611/4885CA2 2854/4885 |
| US-11318216-B2 | Method for producing radiohalogen-labeled compound and method for producing radiopharmaceutical | RER1, MLX, MRPL21 | CA12 2858/4885CA1 3679/4885CA2 4066/4885 |
| US-10703726-B2 | Method for producing radiopharmaceutical composition | NAA15, TMEM14C, FLNA | CA12 1974/4885CA1 3521/4885CA2 2455/4885 |
| US-20190276411-A1 | Method for Producing Radiopharmaceutical Composition | NAA15, TMEM14C, FLNA | CA12 1974/4885CA1 3521/4885CA2 2455/4885 |
| US-20170066748-A1 | RADIOACTIVE FLUORINE LABELING PRECURSOR COMPOUND AND METHOD FOR MANUFACTURING RADIOACTIVE FLUORINE LABELED COMPOUND USING THE SAME | AFF1, NPFFR1, AFF2 | CA12 535/4885CA1 3259/4885CA2 3956/4885 |
| US-20200121811-A1 | METHOD FOR PRODUCING RADIOHALOGEN-LABELED COMPOUND AND METHOD FOR PRODUCING RADIOPHARMACEUTICAL | RER1, MLX, MRPL21 | CA12 2858/4885CA1 3679/4885CA2 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.